International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 418-425 , 1 June 2005

Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer

Presented in part at the 45th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology.

  • Patrick Cheung, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests to: Patrick Cheung, M.D., Toronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Ave., Toronto, Ontario, Canada, M4N 3M5; Tel: (416) 480-6165; Fax: (416) 217-1338
    • ,
  • Katharina Sixel, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Gerard Morton, M.B.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • D. Andrew Loblaw, M.D., M.Sc.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Romeo Tirona, B.Sc.

      Affiliations

    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Geordi Pang, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Richard Choo, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Ewa Szumacher, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Gerrit DeBoer, Ph.D.

      Affiliations

    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Jean-Philippe Pignol, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Toronto-Sunnybrook Regional Cancer Centre, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada

Received 2 June 2004 ,Revised 28 September 2004 ,Accepted 30 September 2004.

References 

  1. Bagshaw MA , Cox RS , Hancock SL . Control of prostate cancer with radiotherapy (Long-term results) . J Urol . 1994;152:1781–1785
  2. Zietman AL , Coen JJ , Dallow KC , et al.   The treatment of prostate cancer by conventional radiation therapy (An analysis of long-term outcome) . Int J Radiat Oncol Biol Phys . 1995;32:287–292
  3. Catton C , Gospodarowicz M , Mui J , et al.   Clinical and biochemical outcome of conventional dose radiotherapy for localized prostate cancer . Can J Urol . 2002;9:1444–1452
  4. Pollack A , Zagars GK . External beam radiotherapy dose response of prostate cancer . Int J Radiat Oncol Biol Phys . 1997;39:1011–1018
  5. Hanks GE , Hanlon AL , Schultheiss TE , et al.   Dose escalation with 3D conformal treatment (Five year outcomes, treatment optimization, and future directions) . Int J Radiat Oncol Biol Phys . 1998;41:501–510
  6. Kuban DA , Thames HD , Levy LB , et al.   Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era . Int J Radiat Oncol Biol Phys . 2003;57:915–928
  7. Zelefsky MJ , Leibel SA , Gaudin PB , et al.   Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer . Int J Radiat Oncol Biol Phys . 1998;41:491–500
  8. Zelefsky MJ , Fuks Z , Hunt M , et al.   High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer . J Urol . 2001;166:876–881
  9. Pollack A , Zagars GK , Starkschall G , et al.   Prostate cancer radiation dose response (Results of the M. D. Anderson phase III randomized trial) . Int J Radiat Oncol Biol Phys . 2002;53:1097–1105
  10. Brenner DJ , Hall EJ . Fractionation and protraction for radiotherapy of prostate carcinoma . Int J Radiat Oncol Biol Phys . 1999;43:1095–1101
  11. Fowler J , Chappell R , Ritter M . Is alpha/beta for prostate tumors really low? . Int J Radiat Oncol Biol Phys . 2001;50:1021–1031
  12. Brenner DJ , Martinez AA , Edmundson GK , et al.   Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue . Int J Radiat Oncol Biol Phys . 2002;52:6–13
  13. Wang JZ , Guerrero M , Li XA . How low is the alpha/beta ratio for prostate cancer? . Int J Radiat Oncol Biol Phys . 2003;55:194–203
  14. Wang JZ , Li XA , Yu CX , et al.   The low alpha/beta ratio for prostate cancer (What does the clinical outcome of HDR brachytherapy tell us?) . Int J Radiat Oncol Biol Phys . 2003;57:1101–1108
  15. Kal HB , Van Gellekom MP . How low is the alpha/beta ratio for prostate cancer? . Int J Radiat Oncol Biol Phys . 2003;57:1116–1121
  16. Skwarchuk MW , Jackson A , Zelefsky MJ , et al.   Late rectal toxicity after conformal radiotherapy of prostate cancer (I) (Multivariate analysis and dose-response) . Int J Radiat Oncol Biol Phys . 2000;47:103–113
  17. Jackson A , Skwarchuk MW , Zelefsky MJ , et al.   Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms . Int J Radiat Oncol Biol Phys . 2001;49:685–698
  18. Fiorino C , Sanguineti G , Cozzarini C , et al.   Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer . Int J Radiat Oncol Biol Phys . 2003;57:953–962
  19. Kuban D , Pollack A , Huang E , et al.   Hazards of dose escalation in prostate cancer radiotherapy . Int J Radiat Oncol Biol Phys . 2003;57:1260–1268
  20. Pang G , Rowlands JA . Electronic portal imaging with an avalanche-multiplication-based video camera . Med Phys . 2000;27:676–684
  21. Lukka H , Warde P , Pickles T , et al.   Controversies in prostate cancer radiotherapy (Consensus development) . Can J Urol . 2001;8:1314–1322
  22. Ruschin M , Sixel K . Integration of digital fluoroscopy with CT-based radiation therapy planning of lung tumours . Med Phys . 2002;29:1698–1709
  23. Aubin S , Beaulieu L , Pouliot S , et al.   Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID . Med Phys . 2003;30:1825–1832
  24. Trotti A , Byhardt R , Stetz J , et al.   Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy . Int J Radiat Oncol Biol Phys . 2000;47:13–47
  25. Cox JD , Stetz J , Pajak TF . Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) . Int J Radiat Oncol Biol Phys . 1995;31:1341–1346
  26. Ryu JK , Winter K , Michalski JM , et al.   Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy) . Int J Radiat Oncol Biol Phys . 2002;54:1036–1046
  27. Michalski JM , Winter K , Purdy JA , et al.   Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV . Int J Radiat Oncol Biol Phys . 2004;58:735–742
  28. Storey MR , Pollack A , Zagars G , et al.   Complications from radiotherapy dose escalation in prostate cancer (Preliminary results of a randomized trial) . Int J Radiat Oncol Biol Phys . 2000;48:635–642
  29. Zelefsky MJ , Fuks Z , Hunt M , et al.   High-dose intensity modulated radiation therapy for prostate cancer (Early toxicity and biochemical outcome in 772 patients) . Int J Radiat Oncol Biol Phys . 2002;53:1111–1116
  30. Huang E , Dong L , Chandra A , et al.   Intrafraction prostate motion during IMRT for prostate cancer . Int J Radiat Oncol Biol Phys . 2002;53:261–268
  31. Madsen BL , Hsi RA , Pham HT , et al.   Intrafractional stability of the prostate using a stereotactic radiotherapy technique . Int J Radiat Oncol Biol Phys . 2003;57:1285–1291
  32. Dawson LA , Litzenberg DW , Brock KK , et al.   A comparison of ventilatory prostate movement in four treatment positions . Int J Radiat Oncol Biol Phys . 2000;48:319–323
  33. Malone S , Crook JM , Kendal WS , et al.   Respiratory-induced prostate motion (Quantification and characterization) . Int J Radiat Oncol Biol Phys . 2000;48:105–109
  34. Kitamura K , Shirato H , Seppenwoolde Y , et al.   Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions . Int J Radiat Oncol Biol Phys . 2002;53:1117–1123
  35. Vigneault E , Pouliot J , Laverdiere J , et al.   Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation (A clinical study) . Int J Radiat Oncol Biol Phys . 1997;37:205–212
  36. Alasti H , Petric MP , Catton CN , et al.   Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate . Int J Radiat Oncol Biol Phys . 2001;49:869–884
  37. Dehnad H , Nederveen AJ , van der Heide UA , et al.   Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation . Radiother Oncol . 2003;67:295–302
  38. Herman MG , Pisansky TM , Kruse JJ , et al.   Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device . Int J Radiat Oncol Biol Phys . 2003;57:1131–1140
  39. Pouliot J , Aubin M , Langen KM , et al.   (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device . Int J Radiat Oncol Biol Phys . 2003;56:862–866
  40. Poggi MM , Gant DA , Sewchand W , et al.   Marker seed migration in prostate localization . Int J Radiat Oncol Biol Phys . 2003;56:1248–1251
  41. van Herk M , Bruce A , Kroes AP , et al.   Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration . Int J Radiat Oncol Biol Phys . 1995;33:1311–1320
  42. Stroom JC , de Boer HC , Huizenga H , et al.   Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability . Int J Radiat Oncol Biol Phys . 1999;43:905–919
  43. Padhani AR , Khoo VS , Suckling J , et al.   Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI . Int J Radiat Oncol Biol Phys . 1999;44:525–533
  44. Mohan DS , Kupelian PA , Willoughby TR . Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland . Int J Radiat Oncol Biol Phys . 2000;46:575–580
  45. Morr J , DiPetrillo T , Tsai JS , et al.   Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer . Int J Radiat Oncol Biol Phys . 2002;53:1124–1129
  46. Serago CF , Chungbin SJ , Buskirk SJ , et al.   Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy . Int J Radiat Oncol Biol Phys . 2002;53:1130–1138
  47. Little DJ , Dong L , Levy LB , et al.   Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT (Implications for treatment margins) . Int J Radiat Oncol Biol Phys . 2003;56:1218–1224
  48. Trichter F , Ennis RD . Prostate localization using transabdominal ultrasound imaging . Int J Radiat Oncol Biol Phys . 2003;56:1225–1233
  49. Langen KM , Pouliot J , Anezinos C , et al.   Evaluation of ultrasound-based prostate localization for image-guided radiotherapy . Int J Radiat Oncol Biol Phys . 2003;57:635–644
  50. Artignan X , Smitsmans MH , Lebesque JV , et al.   Online ultrasound image guidance for radiotherapy of prostate cancer (Impact of image acquisition on prostate displacement) . Int J Radiat Oncol Biol Phys . 2004;59:595–601
  51. Mackie TR , Kapatoes J , Ruchala K , et al.   Image guidance for precise conformal radiotherapy . Int J Radiat Oncol Biol Phys . 2003;56:89–105
  52. Jaffray DA , Siewerdsen JH , Wong JW , et al.   Flat-panel cone-beam computed tomography for image-guided radiation therapy . Int J Radiat Oncol Biol Phys . 2002;53:1337–1349
  53. Teh BS , Bastasch MD , Wheeler TM , et al.   IMRT for prostate cancer (Defining target volume based on correlated pathologic volume of disease) . Int J Radiat Oncol Biol Phys . 2003;56:184–191
  54. Teh BS , Bastasch MD , Mai WY , et al.   Predictors of extracapsular extension and its radial distance in prostate cancer (Implications for prostate IMRT, brachytherapy, and surgery) . Cancer J . 2003;9:454–460
  55. Badiozamani KR , Wallner K , Cavanagh W , et al.   Comparability of CT-based and TRUS-based prostate volumes . Int J Radiat Oncol Biol Phys . 1999;43:375–378
  56. Narayana V , Roberson PL , Pu AT , et al.   Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants . Int J Radiat Oncol Biol Phys . 1997;37:1181–1185
  57. Hoffelt SC , Marshall LM , Garzotto M , et al.   A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer . Int J Radiat Oncol Biol Phys . 2003;57:29–32
  58. Roach M , Faillace-Akazawa P , Malfatti C , et al.   Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy . Int J Radiat Oncol Biol Phys . 1996;35:1011–1018
  59. Milosevic M , Voruganti S , Blend R , et al.   Magnetic resonance imaging (MRI) for localization of the prostatic apex (Comparison to computed tomography (CT) and urethrography) . Radiother Oncol . 1998;47:277–284
  60. Parker CC , Damyanovich A , Haycocks T , et al.   Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration . Radiother Oncol . 2003;66:217–224
  61. Collins CD , Lloyd-Davies RW , Swan AV . Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique . Clin Oncol (R Coll Radiol) . 1991;3:127–132
  62. Livsey JE , Cowan RA , Wylie JP , et al.   Hypofractionated conformal radiotherapy in carcinoma of the prostate (Five-year outcome analysis) . Int J Radiat Oncol Biol Phys . 2003;57:1254–1259
  63. Yeoh EE , Fraser RJ , McGowan RE , et al.   Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma (Early results of a phase III randomized trial) . Int J Radiat Oncol Biol Phys . 2003;55:943–955
  64. Lukka H , Hayter C , Warde P , et al.   A randomized trial comparing two fractionation schedules for patients with localized prostate cancer . [abstract] Int J Radiat Oncol Biol Phys . 2003;57:S126
  65. Kupelian PA , Reddy CA , Carlson TP , et al.   Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer . Int J Radiat Oncol Biol Phys . 2002;53:904–912
  66. Logue JP , Cowan RA , Hendry JH . Hypofractionation for prostate cancer . Int J Radiat Oncol Biol Phys . 2001;49:1522–1523
  67. Catton C , Chung P , Haycocks T , et al.   Hypofractionated intensity modulated radiation therapy for prostate cancer . [Abstract] Int J Radiat Oncol Biol Phys . 2002;54:188
  68. Galalae RM , Martinez A , Mate T , et al.   Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer . Int J Radiat Oncol Biol Phys . 2004;58:1048–1055

 Funded by the Abbott-CARO Uro-Oncologic Radiation Award (ACURA) and the Toronto-Sunnybrook Regional Cancer Centre Intramural Research Fund.

PII: S0360-3016(04)02703-8

doi: 10.1016/j.ijrobp.2004.09.051

International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 418-425 , 1 June 2005

Article Tools

* Image Usage & Resolution